companydata.dkONCONOX ApS: Financial statements 2012
CVR: 33858965
ONCONOX ApS (CVR 33858965) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK -705,254 and a net result of DKK -712,491. Equity amounted to DKK 240,481. The solvency ratio was 73.8%.
- Gross Profit
- -705,254 kr.
- Profit/Loss
- -712,491 kr.
- Equity
- 240,481 kr.
- Total Assets
- 325,704 kr.
How creditworthy is ONCONOX ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2012
As of June 22, 2012, JUT NR. 2180 A/S has been appointed auditor of ONCONOX ApS.
As of June 22, 2012, EY Danmark A/S has stepped down as auditor of ONCONOX ApS.
About ONCONOX ApS
ONCONOX ApS was a Danish company of the type Anpartsselskab based in Greve, founded in 2011. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company is owned by Amme Pharmaceuticals, Inc.. The company has 0 employees. In 2022, the company reported a net result of DKK -40,672 compared with DKK -43,846 the year before. Equity amounted to DKK -4,305.